A Brief Colonial History Of Ceylon(SriLanka)
Sri Lanka: One Island Two Nations
A Brief Colonial History Of Ceylon(SriLanka)
Sri Lanka: One Island Two Nations
(Full Story)
Search This Blog
Back to 500BC.
==========================
Thiranjala Weerasinghe sj.- One Island Two Nations
?????????????????????????????????????????????????Sunday, April 26, 2015
When the hospital’s drug cabinet is bare

Carbapenem-resistant Enterobacteriaceae. (Centers for Disease Control and Prevention via Reuters)
By Lenny Bernstein April 24
I worry about a lot of things that could go wrong if I'm taken to a hospital, but until today this hasn't been one of them: Hospitals are routinely running short of critical antibiotics, often for months at a time.
I worry about a lot of things that could go wrong if I'm taken to a hospital, but until today this hasn't been one of them: Hospitals are routinely running short of critical antibiotics, often for months at a time.
When Larissa May, an associate professor of emergency medicine at George
Washington University, and a team of researchers checked, they found
that hospitals across the country ran short of 148 anti-bacterial drugs over
a 13-year period, from 2001 to 2013. The average time without a drug
was nearly nine months (injectable drugs generally ran short for even
longer periods than medications taken by mouth). Thirty-two of the
medications ran short more than once, including one, Meropenem, which
was short seven different times for a total of 1,114 days.
These were not exotic pharmaceuticals that were needed now and then.
We're talking about front-line antibiotics used to treat various
infections, including multidrug-resistant bacteria such as MRSA,
carbapenem-resistant Enterobacteriaceae and clostridium difficile. In
some cases, the only drug available against a certain infection ran
short.
There's no question that "these shortages often impact clinicians'
ability to treat infections," May wrote. In a 2010 survey, clinicians
reported "adverse outcomes" because of drug shortages in 20 percent of
their cases. May's research team did not look for fatalities, so it's
unclear whether any resulted from a drug shortage.
"It's pretty scary, really," May told me in an interview. "There are
some infections for which there are very limited alternatives, or no
alternatives for that drug." So in some cases, the drug cupboard is
simply bare, she said.
We've all heard of drug-resistant bacteria and the problem of
over-prescribing antibiotics. But I doubt the average person understands
it's possible to be admitted to a hospital for a serious infection and
have the doctor say the pharmacy is simply out of the drug he needs. But
it happens all the time, according to the data May's team compiled from
a database run by the University of Utah Drug Information Service. The
study was published in the journal Clinical Infectious Diseases.
For example, injectable doxycycline, used to treat Lyme disease,
pneumonia and urinary tract infections, ran short three times during the
study period, for a total of 1,515 days.
Vancomycin, used to treat severe skin infections and endocarditis, among
other conditions, ran short three times for 373 days and was still on
shortage when the study ended.
The Food and Drug Administration defines a drug shortage as a period
when total supply of various versions of antibiotics is inadequate to
meet projected demand "at the user level." Individual hospitals may or
may not have some on hand, depending on recent use.
There are several reasons why this happens, according to the study. Drug
companies have been merging, prompting consolidation of their
manufacturing facilities. The profit margin for antibiotics is thin,
providing little incentive for those companies to come out with new
drugs. Some drugs, such as one for the treatment of Pneumocystis
pneumonia, are produced by a single manufacturer.
Communication between hospital pharmacies and drug manufacturers also
needs improvement, the research concludes. "In half of cases, physicians
and nurses learn about drug shortages from pharmacy staff, often when
the pharmacy is unable to dispense the medication," they wrote.
May said she is hopeful that a new federal government program to create
incentives for development of new antibiotics will be helpful, and she
suggested that manufacturers be required to alert hospitals when drugs
are running short.



